A
Agilent Technologies, Inc.
NYSEUSDEQUITY
DELAYED
Last price
159.50
▲ 3.20 (2.05%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
156.30
Prev close
156.30
Day high
160.47
Day low
155.28
Volume
2.73M
Market cap
—
P/E (TTM)
—
52W range
108.35 – 160.51
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+7.05%
+8.4%
1M
+13.78%
+10.1%
3M
+38.51%
+35.4%
6M
+29.37%
+18.3%
YTD
+16.85%
+4.6%
1Y
+33.49%
+13.5%
3Y
+31.02%
-43.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $6.95B | $6.51B | $6.83B | $6.85B | +6.7% |
| Operating revenue | $6.95B | $6.51B | $6.83B | $6.85B | +6.7% |
| Cost of revenue | $3.31B | $2.98B | $3.37B | $3.13B | +11.1% |
| Gross profit | $3.64B | $3.54B | $3.46B | $3.72B | +3.1% |
| Research & development | $455.00M | $479.00M | $481.00M | $467.00M | -5.0% |
| Selling, general & admin | $1.71B | $1.57B | $1.63B | $1.64B | +9.0% |
| Total operating expense | $2.16B | $2.05B | $2.12B | $2.10B | +5.7% |
| Operating income | $1.48B | $1.49B | $1.35B | $1.62B | -0.6% |
| Net interest income | -$50.00M | -$16.00M | -$44.00M | -$75.00M | -212.5% |
| Pre-tax income | $1.44B | $1.52B | $1.34B | $1.50B | -5.7% |
| Tax provision | $132.00M | $232.00M | $99.00M | $250.00M | -43.1% |
| Net income | $1.30B | $1.29B | $1.24B | $1.25B | +1.1% |
| Net income to common | $1.30B | $1.29B | $1.24B | $1.25B | +1.1% |
| Basic EPS | 4.59 | 4.44 | 4.22 | 4.19 | +3.4% |
| Diluted EPS | 4.57 | 4.43 | 4.19 | 4.18 | +3.2% |
| EBIT | $1.55B | $1.62B | $1.43B | $1.59B | -4.3% |
| EBITDA | $1.83B | $1.87B | $1.71B | $1.91B | -2.1% |
| Basic shares | 284.00M | 290.00M | 294.00M | 299.00M | -2.1% |
| Diluted shares | 285.00M | 291.00M | 296.00M | 300.00M | -2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.79B | $1.33B | $1.59B | $1.05B | +34.6% |
| Cash & short-term investments | $1.79B | $1.33B | $1.59B | $1.05B | +34.6% |
| Accounts receivable | $1.49B | $1.32B | $1.29B | $1.41B | +12.3% |
| Inventory | $1.02B | $972.00M | $1.03B | $1.04B | +5.5% |
| Total current assets | $4.59B | $3.96B | $4.19B | $3.78B | +16.0% |
| Property, plant & equipment | $2.02B | $1.78B | $1.27B | $1.10B | +13.8% |
| Goodwill & intangibles | $4.92B | $5.02B | $4.43B | $4.77B | -2.1% |
| Total assets | $12.73B | $11.85B | $10.76B | $10.53B | +7.4% |
| Total current liabilities | $2.35B | $1.90B | $1.60B | $1.86B | +23.9% |
| Current debt | $304.00M | $45.00M | — | $36.00M | +575.6% |
| Long-term debt | $3.05B | $3.35B | $2.73B | $2.73B | -8.8% |
| Total debt | $3.35B | $3.39B | $2.73B | $2.77B | -1.1% |
| Total liabilities | $5.99B | $5.95B | $4.92B | $5.23B | +0.6% |
| Retained earnings | $1.39B | $750.00M | $782.00M | $324.00M | +85.2% |
| Shareholder equity | $6.74B | $5.90B | $5.84B | $5.30B | +14.3% |
| Working capital | $2.25B | $2.06B | $2.58B | $1.92B | +8.9% |
| Net tangible assets | $1.82B | $874.00M | $1.41B | $532.00M | +108.6% |
| Shares issued | 283.05M | 285.19M | 292.12M | 295.00M | -0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.30B | $1.29B | $1.24B | $1.25B | +1.1% |
| Depreciation & amortisation | $288.00M | $257.00M | $271.00M | $317.00M | +12.1% |
| Stock-based compensation | $128.00M | $129.00M | $111.00M | $125.00M | -0.8% |
| Change in working capital | -$131.00M | $83.00M | -$116.00M | -$478.00M | -257.8% |
| Operating cash flow | $1.56B | $1.75B | $1.77B | $1.31B | -11.0% |
| Capital expenditure | -$407.00M | -$378.00M | -$298.00M | -$291.00M | -7.7% |
| Investing cash flow | -$394.00M | -$1.26B | -$310.00M | -$338.00M | +68.7% |
| Share buybacks | -$425.00M | -$1.15B | -$575.00M | -$1.14B | +63.0% |
| Dividends paid | -$282.00M | -$274.00M | -$265.00M | -$250.00M | -2.9% |
| Financing cash flow | -$715.00M | -$752.00M | -$930.00M | -$1.37B | +4.9% |
| Free cash flow | $1.15B | $1.37B | $1.47B | $1.02B | -16.1% |
| End cash position | $1.79B | $1.33B | $1.59B | $1.06B | +34.5% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.83B | $1.80B | $1.86B | $1.74B | $1.67B | +2.1% |
| Operating revenue | $1.83B | $1.80B | $1.86B | $1.74B | $1.67B | +2.1% |
| Cost of revenue | $845.00M | $852.00M | $871.00M | $850.00M | $802.00M | -0.8% |
| Gross profit | $990.00M | $946.00M | $990.00M | $888.00M | $866.00M | +4.7% |
| Research & development | $126.00M | $117.00M | $119.00M | $111.00M | $112.00M | +7.7% |
| Selling, general & admin | $465.00M | $476.00M | $428.00M | $417.00M | $454.00M | -2.3% |
| Total operating expense | $591.00M | $593.00M | $547.00M | $528.00M | $566.00M | -0.3% |
| Operating income | $399.00M | $353.00M | $443.00M | $360.00M | $300.00M | +13.0% |
| Net interest income | -$12.00M | -$10.00M | -$10.00M | -$12.00M | -$15.00M | -20.0% |
| Pre-tax income | $408.00M | $364.00M | $442.00M | $366.00M | $260.00M | +12.1% |
| Tax provision | $69.00M | $59.00M | $8.00M | $30.00M | $45.00M | +16.9% |
| Net income | $339.00M | $305.00M | $434.00M | $336.00M | $215.00M | +11.1% |
| Net income to common | $339.00M | $305.00M | $434.00M | $336.00M | $215.00M | +11.1% |
| Basic EPS | 1.20 | 1.08 | 1.53 | 1.18 | 0.75 | +11.1% |
| Diluted EPS | 1.20 | 1.07 | 1.53 | 1.18 | 0.75 | +12.1% |
| EBIT | $433.00M | $389.00M | $469.00M | $394.00M | $289.00M | +11.3% |
| EBITDA | $500.00M | $456.00M | $540.00M | $466.00M | $362.00M | +9.6% |
| Basic shares | 282.00M | 283.00M | 283.00M | 284.00M | 285.00M | -0.4% |
| Diluted shares | 283.00M | 284.00M | 284.00M | 285.00M | 285.00M | -0.4% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | +2.8% |
| Cash & short-term investments | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | +2.8% |
| Accounts receivable | $1.50B | $1.52B | $1.49B | $1.09B | $1.08B | -1.5% |
| Inventory | $1.09B | $1.06B | $1.02B | $1.01B | $991.00M | +2.8% |
| Total current assets | $4.76B | $4.62B | $4.59B | $4.25B | $4.21B | +3.2% |
| Property, plant & equipment | $2.10B | $2.08B | $2.02B | $1.97B | $1.91B | +1.0% |
| Goodwill & intangibles | $4.89B | $4.91B | $4.92B | $4.94B | $4.97B | -0.4% |
| Total assets | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | +2.0% |
| Total current liabilities | $2.27B | $2.23B | $2.35B | $1.89B | $2.01B | +1.6% |
| Current debt | $304.00M | $304.00M | $304.00M | $59.00M | $146.00M | 0.0% |
| Long-term debt | $3.05B | $3.05B | $3.05B | $3.35B | $3.35B | +0.0% |
| Total debt | $3.35B | $3.35B | $3.35B | $3.41B | $3.50B | +0.0% |
| Total liabilities | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | +0.6% |
| Retained earnings | $1.69B | $1.48B | $1.39B | $1.10B | $912.00M | +14.0% |
| Shareholder equity | $7.12B | $6.91B | $6.74B | $6.37B | $6.14B | +3.1% |
| Working capital | $2.49B | $2.38B | $2.25B | $2.36B | $2.20B | +4.7% |
| Net tangible assets | $2.23B | $2.00B | $1.82B | $1.43B | $1.17B | +11.7% |
| Shares issued | 282.22M | 282.70M | 283.05M | 283.59M | 283.94M | -0.2% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $339.00M | $305.00M | $434.00M | $336.00M | $215.00M | +11.1% |
| Depreciation & amortisation | $67.00M | $67.00M | $71.00M | $72.00M | $73.00M | 0.0% |
| Stock-based compensation | $32.00M | $41.00M | $26.00M | $32.00M | $30.00M | -22.0% |
| Change in working capital | -$211.00M | -$180.00M | $85.00M | -$82.00M | -$136.00M | -17.2% |
| Operating cash flow | $277.00M | $268.00M | $545.00M | $362.00M | $221.00M | +3.4% |
| Capital expenditure | -$76.00M | -$93.00M | -$93.00M | -$103.00M | -$114.00M | +18.3% |
| Investing cash flow | -$77.00M | -$93.00M | -$90.00M | -$96.00M | -$114.00M | +17.2% |
| Share buybacks | -$65.00M | -$152.00M | -$85.00M | -$85.00M | -$165.00M | +57.2% |
| Dividends paid | -$72.00M | -$72.00M | -$70.00M | -$71.00M | -$70.00M | 0.0% |
| Financing cash flow | -$144.00M | -$222.00M | -$200.00M | -$219.00M | -$116.00M | +35.1% |
| Free cash flow | $201.00M | $175.00M | $452.00M | $259.00M | $107.00M | +14.9% |
| End cash position | $1.81B | $1.76B | $1.79B | $1.54B | $1.49B | +2.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
151.19
+5.50% from price
SMA 20
145.76
+9.09% from price
SMA 50
137.52
+15.62% from price
SMA 100
128.53
+24.10% from price
SMA 200
131.30
+21.10% from price
EMA 12
150.34
+6.09% from price
EMA 26
144.98
+10.01% from price
EMA 50
139.31
+14.49% from price
RSI (14)
80.5
Overbought
MACD (12,26,9)
5.36
Hist 1.02
ATR (14)
3.81
2.39% of price
Realised vol 30D
25.9%
Annualised
Bollinger upper
158.29
20, 2σ
Bollinger lower
133.22
20, 2σ
50 / 200 cross
Golden
137.52 vs 131.30
Trend bias
Above 200
+21.10%
Risk profile
Beta vs SPY
0.88
Less volatile than market
Correlation to SPY
0.34
Loosely linked
Realised vol 30D
25.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.9%
Peak to trough
Max drawdown 5Y
-44.6%
Peak to trough
ATR 14
3.81
2.39% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore
24/7 Wall St. · 1d ago
Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS
Zacks · 1d ago
What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?
Barchart · 2d ago
MDT vs. A: Which Stock Should Value Investors Buy Now?
Zacks · 4d ago
Cannabis Testing Services Market Research Report 2026-2031: Profiles Agilent, Eurofins, SGS, and 18 Other Companies
GlobeNewswire · 4d ago
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Zacks · 4d ago
Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test
Simply Wall St. · 16d ago
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.